Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.090 +0.110 (+5.56%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
38 39 Next >
News headline image
Why Cassava Sciences Stock Is Trading Higher Today ↗
Cassava Sciences Inc (NASDAQ: SAVA) is trading higher Tuesday after the company was informed by Neuroscience journal that there was no evidence to support data manipulation... 
Via Benzinga
News headline image
SAVA Stock: The Social Media Chatter That Has Cassava Sciences Trending Today ↗
Cassava Sciences (SAVA) stock is getting some extra attention today from traders on social media and we've got all the details. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8... 
Via Benzinga
News headline image
26 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains... 
Via Benzinga
Quick Take Technical Analysis: Cassava Sciences, Inc ↗
Cassava Sciences, Inc (NASDAQ:SAVA) fell over 5% on Tuesda... 
Via Benzinga
News headline image
65 Biggest Movers From Yesterday ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... 
Via Benzinga
News headline image
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts ↗
These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. 
Via InvestorPlace
News headline image
2 Big Stock Bets That Are Insiders Are Buying Now ↗
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
News headline image
CORRECTING and REPLACING CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
While Cassava Sciences Is a Risky Play, It Has Substantial Payoff Potential ↗
Informed investors who can handle its high risk may want to take a look at speculative biotech play SAVA stock. 
Via InvestorPlace
News headline image
Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ: 
Via Benzinga
News headline image
Should Investors Worry About the Federal Investigation of Cassava? ↗
The investigation really isn't the underlying concern. 
Via The Motley Fool
News headline image
Cassava Sciences Just Returned to the Buy Zone ↗
There's no need to panic about SAVA stock, as Cassava Sciences just launched an important study focused on treating Alzheimer's disease. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... 
Via Benzinga
News headline image
Cassava Sciences Kickstarts Second Late-Stage Alzheimer's Trial With Simufilam ↗
Cassava Sciences Inc (NASDAQ: SAVA) has initiated a second Phase 3 study of simufilam in patients with Alzheimer's disease. The second Phase 3 study is... 
Via Benzinga
News headline image
3 Biotech Stocks That Have More Than Tripled so far This Year ↗
But can they keep up the momentum? 
Via The Motley Fool
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped... 
Via Benzinga
Topics Initial Public Offering
News headline image
2 More Stocks Set to 2x… 5x… 10x in 2022 ↗
Finding 10x stocks is possible; it's simply a matter of knowing what patterns to look for. Here are a couple of strong contenders. 
Via InvestorPlace
Topics Economy
News headline image
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher ↗
Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also fell, dropping 0.23% to 4,690.24. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
See Why Cassava Sciences Shares Are Falling On Wednesday? ↗
The Wall Street Journal reported that the SEC had launched a probe into claims that Cassava Sciences Inc (NASDAQ: SAVA) manipulated data key to its case for... 
Via Benzinga
Topics Regulatory Compliance
News headline image
Why Cassava Sciences Is Sliding Lower Today ↗
Allegations of data manipulation that hammered the company -- and its stock price -- this summer won't be easily forgotten. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers EyePoint Pharmaceuticals (NASDAQ:EYP... 
Via Benzinga
News headline image
Today’s Hot Penny Stocks: What’s Moving ZSAN, AVGR and CEI Higher Wednesday? ↗
Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! 
Via InvestorPlace
News headline image
ROKU Stock Price Predictions: How Low One Analyst Thinks Roku Will Go ↗
Roku (ROKU) stock price predictions aren't doing the shares any favors on Wednesday after one analyst put out a bearish take. 
Via InvestorPlace
News headline image
Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge ↗
Midway through trading Wednesday, the Dow traded down 0.51% to 35,958.22 while the NASDAQ rose 0.03% to 15,977.88. The S&P also fell, dropping 0.13% to 4,694.96. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
42 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed... 
Via Benzinga
Topics Initial Public Offering
News headline image
SAVA Stock Alert: The SEC Investigation That Has Cassava Sciences Cratering Today ↗
Cassava Sciences (SAVA) stock is on the move Wednesday as investors react to reports of an SEC investigation over possible data manipulation. 
Via InvestorPlace
Topics Regulatory Compliance
News headline image
Cassava Sciences In Hot Water Again As Shorts Claim 'Extreme' Data Manipulation ↗
In a filing, the short sellers claim the science backing Cassava's drug is impossible. 
Via Investor's Business Daily
News headline image
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cassava Sciences, Inc. (NASDAQ: 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.